Found: 15
Select item for more details and to access through your institution.
Nasopharyngeal Viral Load Is the Major Driver of Incident Antibody Immune Response to SARS-CoV-2 Infection.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 12, p. 1, doi. 10.1093/ofid/ofad598
- By:
- Publication type:
- Article
A Prospective Study of Key Correlates for Household Transmission of Severe Acute Respiratory Syndrome Coronavirus 2.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 7, p. 1, doi. 10.1093/ofid/ofad271
- By:
- Publication type:
- Article
Effectiveness of Casirivimab and Imdevimab Antibody Combination in Immunocompromised Hospitalized Patients With Coronavirus Disease 2019: A Post Hoc Analysis in a Phase 1/2/3 Double–Blind Trial.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 5, p. 1, doi. 10.1093/ofid/ofad211
- By:
- Publication type:
- Article
Elevated serum IgA following vaccination against SARS-CoV-2 in a cohort of high-risk first responders.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-19095-7
- By:
- Publication type:
- Article
Concordance between SARS-CoV-2 index individuals and their household contacts on index individual COVID-19 transmission cofactors: a comparison of self-reported and contact-reported information.
- Published in:
- BMC Public Health, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12889-024-18371-7
- By:
- Publication type:
- Article
Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-39292-w
- By:
- Publication type:
- Article
Short-Term Subcutaneous Allergy Immunotherapy and Dupilumab are Well Tolerated in Allergic Rhinitis: A Randomized Trial.
- Published in:
- Journal of Asthma & Allergy, 2021, v. 14, p. 1045, doi. 10.2147/JAA.S318892
- By:
- Publication type:
- Article
Efficacy and Safety of Sarilumab in Hospitalized Patients With Coronavirus Disease 2019: A Randomized Clinical Trial.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e380, doi. 10.1093/cid/ciac153
- By:
- Publication type:
- Article
Assessing the Combined Public Health Impact of Pharmaceutical Interventions on Pandemic Transmission and Mortality: An Example in SARS CoV‐2.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 6, p. 1224, doi. 10.1002/cpt.2728
- By:
- Publication type:
- Article
Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Cat allergen exposure in a naturalistic exposure chamber: A prospective observational study in cat‐allergic subjects.
- Published in:
- Clinical & Experimental Allergy, 2022, v. 52, n. 2, p. 265, doi. 10.1111/cea.14087
- By:
- Publication type:
- Article
Estrogen Reduces Cholecystokinin-Induced c-Fos Expression in the Rat Brain.
- Published in:
- Neuroendocrinology, 1998, v. 67, n. 6, p. 384, doi. 10.1159/000054337
- By:
- Publication type:
- Article
Pharmacokinetics and Concentration‐Response of Dupilumab in Patients With Seasonal Allergic Rhinitis.
- Published in:
- Journal of Clinical Pharmacology, 2022, v. 62, n. 5, p. 689, doi. 10.1002/jcph.2004
- By:
- Publication type:
- Article
Differential modulation of allergic rhinitis nasal transcriptome by dupilumab and allergy immunotherapy.
- Published in:
- Allergy, 2024, v. 79, n. 4, p. 894, doi. 10.1111/all.16001
- By:
- Publication type:
- Article
Anti-SARS-CoV-2 IgA Identifies Asymptomatic Infection in First Responders.
- Published in:
- 2022
- By:
- Publication type:
- Journal Article